206
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Should We Assess Tumorigenicity With the Peto or Poly-k Test?

Pages 118-124 | Received 01 Apr 2010, Published online: 10 Aug 2012

References

  • Armitage , P. 1955 . “Tests for Linear Trends in Proportions and Frequencies” . Biometrics , 11 : 375 – 386 .
  • Bailer , A. J. and Portier , C. J. 1988 . “Effects of Treatment-Induced Mortality and Tumor-Induced Mortality on Tests for Carcinogenicity in Small Samples” . Biometrics , 44 : 417 – 431 .
  • Bieler , G. S. and Williams , R. L. 1993 . “Ratio Estimates, the Delta Method, and Quantal Response Tests for Increased Carcinogenicity” . Biometrics , 49 : 793 – 801 .
  • Cochran , W. G. 1954 . “Some Methods for Strengthening the Common χ2 Tests” . Biometrics , 10 : 417 – 451 .
  • Fairweather , W.R. 1998 . “Biostatistical Methodology in Carcinogenicity Studies” . Drug Information Journal , 32 : 401 – 421 .
  • Fieser , L. F. 1938 . “Carcinogenic Activity, Structure and Chemical Reactivity of Polynuclear Aromatic Hydrocarbons” . American Journal of Cancer , 34 : 37 – 124 .
  • Gaylor , D. W. and Kodell , R. L. 1999 . “Dose-Response Trend Tests for Tumorigenesis, Adjusted for Body Weight” . Toxicological Sciences , 49 : 318 – 323 .
  • Gaylor , D. W. and Kodell , R. L. 2001 . “Dose-Response Trend Tests for Tumorigenesis Adjusted for Differences in Survival and Body Weight Across Doses” . Toxicological Sciences , 59 : 219 – 225 .
  • Hoel , D. G. and Walburg , H. E. 1972 . “Statistical Analysis of Survival Experiments” . Journal of the National Cancer Institute , 49 : 361 – 372 .
  • Kodell , R. L. , Blackwell , B.-N. , Bucci , T. J. and Greenman , D. L. 1995 . “Cause-of-Death Assignment at the National Center for Toxicological Research” . Toxicologic Pathology , 23 : 241 – 247 .
  • Lagakos , S. W. 1982 . “An Evaluation of Some Two-Sample Tests used to Analyze Animal Carcinogenicity Experiments” . Utilitas Mathematica , 21B : 239 – 260 .
  • Lagakos , S. W. and Louis , T. A. 1988 . “Use of Tumour Lethality to Interpret Tumorigenicity Experiments Lacking Cause-of-Death Data” . Applied Statistics , 37 : 169 – 179 .
  • Mantel , N. 1966 . “Evaluation of Survival Data and Two New Rank-Order Statistics Arising in its Consideration” . Cancer Chemotherapy Reports , 50 : 163 – 170 .
  • Mantel , N. and Haenszel , W. 1959 . “Statistical Aspects of the Analysis of Data from Retrospective Studies of Disease” . Journal of the National Cancer Institute , 22 : 719 – 748 .
  • McKnight , B. and Wahrendorf , J. 1992 . “Tumour Incidence Rate Alternatives and the Cause-of-Death Test for Carcinogenicity” . Biometrika , 79 : 131 – 138 .
  • Moon , H. , Ahn , H. and Kodell , R. L. 2002 . “Extension of Peto’s Test by Attribution of Tumor Lethality in the Absence of Cause-of-Death Information” . Biometrical Journal , 44 : 962 – 1001 .
  • Moon , H. , Ahn , H. and Kodell , R. L. 2005 . “An Age-Adjusted Bootstrap-Based Poly-k Test” . Statistics in Medicine , 24 : 1233 – 1244 .
  • Moon , H. , Ahn , H. , Kodell , R. L. and Lee , J. J. 2003 . “Estimation of k for the Poly-k Test with Application to Animal Carcinogenicity Studies” . Statistics in Medicine , 22 : 2619 – 2636 .
  • Moon , H. , Ahn , H. , Kodell , R. L. and Lee , J. J. 2006 . “A Computational Tool for Testing Dose-Related Trend using an Age-Adjusted Bootstrap-Based Poly-k Test” . Journal of Statistical Software , 16 ( 7 ) Available online at http://www.jstatsoft.org/v16/i07
  • National Toxicology Program . 2001 . “Toxicology and Carcinogenesis Studies of Acrylonitrile (CAS NO. 107-13-1) in B6C3F1 Mice (Gavage Studies),” National Toxicology Program, P.O. Box 12233 , Research Triangle Park . NC 27709. October 2001, NTP TR 506, NIH Publication No. 02-4440
  • Peddada , S. D. and Kissling , G. E. 2006 . “A Survival-Adjusted Quantal-Response Test for Analysis of Tumor Incidence Rates in Animal Carcinogenicity Studies” . Environmental Health Perspectives , 114 : 537 – 541 .
  • Peto , R. 1974 . “Guidelines on the Analysis of Tumour Rates and Death Rates in Experimental Animals” . British Journal of Cancer , 29 : 101 – 105 .
  • Peto , R. , Pike , M. C. , Day , N. E. , Gray , R. G. , Lee , P. N. , Parish , S. , Peto , J. , Richards , S. and Wahrendorf , J. 1980 . “Guidelines for Simple Sensitive Significance Tests for Carcinogenic Effects in Long-Term Animal Experiments” . In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, supplement 2: Long-term and Short-term Screening Assays for Carcinogens: A Critical Appraisal , 311 – 346 . Lyon : International Agency for Research on Cancer .
  • Portier , C. , Hedges , J. and Hoel , D. G. 1986 . “Age-Specific Models of Mortality and Tumor Onset for Historical Control Animals in the National Toxicology Program’s Carcinogenicity Experiments” . Cancer Research , 46 : 4372 – 4378 .
  • Rahman , M. A. and Lin , K. K. 2008 . “A Comparison of False Positive Rates of Peto and Poly-3 Methods for Long-Term Carcinogenicity Data Analysis using Multiple Comparison Adjustment Suggested by Lin and Rahman” . Journal of Biopharmaceutical Statistics , 18 : 949 – 958 .
  • Schaarschmidt , F. , Sill , M. and Hothorn , L. A. 2008 . “Poly-k Trend Tests for Survival Adjusted Analysis of Tumor Rates Formulated as Approximate Multiple Contrast Test” . Journal of Biopharmaceutical Statistics , 18 : 934 – 945 .
  • STP Working Group . 2001a . “Draft Recommendations on Classification of Rodent Neoplasms for Peto Analysis” . Toxicologic Pathology , 29 : 265 – 268 .
  • STP Working Group . 2001b . “The Society of Toxicologic Pathology’s Position on Statistical Methods for Rodent Carcinogenicity Studies” . Toxicologic Pathology , 29 : 670 – 672 .
  • STP Working Group . 2002 . “Statistical Methods for Carcinogenicity Studies” . Toxicologic Pathology , 30 : 403 – 414 .
  • Tarone , R. E. 1975 . “Tests for Trend in Life Table Analysis” . Biometrika , 62 : 679 – 682 .
  • U.S. Food and Drug Administration . 2001 . “Guidance for Industry: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals,” , MD: FDA/CDER : Draft Guidance, Silver Spring .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.